Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2919761 Title: FORME PHARMACEUTIQUE COMPRENANT CYTISINE MICRONISEE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
138265996
WO application number:
IB2013060230
Type:
European patent granted for BE
Status:
Open
Publication number:
2919761
WO publication number:
WO2014076680
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
19/11/2013
Grant date:
15/01/2020
EP publication date:
23/09/2015
WO publication date:
22/05/2014
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
15/01/2020
EP B1 publication date:
15/01/2020
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
19/11/2033

Applicant

Name:
Aflofarm Farmacja Polska SP. Z O.O.
Legal Form:
From:
15/01/2020
Address:
Ul. Partyzancka 133/151, 95-200 Pabianice, Poland (PL)
To:

Agent

Name:
OFFICE FREYLINGER S.A.
Legal Form:
From:
21/04/2020
Address:
Route d'Arlon 234 P.O. Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WAHL, Hanna
Legal Form:
Address:
PL-95-200 Pabianice, Poland (PL)

2

Name:
DABROWA, Marek
Legal Form:
Address:
PL-90-146 Lódz, Poland (PL)

3

Name:
KULAZINSKI, Piotr
Legal Form:
Address:
PL-90-735 Lódz, Poland (PL)

Priority

Priority patent number:
40167612
Priority date:
19/11/2012
Priority country:
Poland (PL)

Classification

IPC or IDT classification:
A61K 9/14; A61K 9/48; A61K 31/435;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2020/02
Publication date:
02/03/2020
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

1

Issue number:
202003
Publication date:
15/01/2020
Description:
Grant (B1)

2

Issue number:
202047
Publication date:
18/11/2020
Description:
Opposition procedure started

Annual fee

Annual fee(s) Due Date:
01/12/2025
Annual fee number:
13
Annual fee amount:
275 Euro
Expected payer:
Last annual fee payment date:
28/10/2024
Last annual fee paid number:
12
Last annual fee paid amount:
240 Euro
Payer:
OFFICE FREYLINGER S.A.
Filing date Document type Publication Type Document Description Number of pages File Type
21/04/2020 Outgoing Correspondence 1 PDF /7/9/4/0/5/0721950497/docs/138265996_0_outgoingcorrespondence_20200422_081927272.pdf
21/04/2020 General Document Declaration of domicile 1 PDF /7/9/4/0/5/0721950497/docs/138265996_1_generaldocument_20200422_081927631.pdf
21/04/2020 Incoming Correspondence (Email) Cover letter 1 PDF /7/9/4/0/5/0721950497/docs/138265996_2_incomingcorrespondenceelectronic_20200422_081928014.pdf